Cite
HARVARD Citation
Wang, W. et al. (2021). Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma. Clinical and translational radiation oncology. pp. 95-99. [Online].